Dynamic Technology Lab’s NovoCure NVCR Stock Holding History

Dynamic Technology Lab’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,910	Closed	-$297K	–	1387
2022 Q3	$297K	Buy	+3,910	New	+$305K	0.03%	811
2022 Q1	–	Sell	-8,928	Closed	-$670K	–	1385
2021 Q4	$670K	Buy	8,928 +1,780	+25%	+$179K	0.07%	458
2021 Q3	$830K	Buy	+7,148	New	+$1.08M	0.1%	322
2020 Q3	–	Sell	-28,158	Closed	-$1.67M	–	1232
2020 Q2	$1.67M	Buy	+28,158	New	+$1.85M	0.25%	79
2020 Q1	–	Sell	-10,841	Closed	-$914K	–	1278
2019 Q4	$914K	Buy	+10,841	New	+$875K	0.15%	216
2017 Q4	–	Sell	-34,828	Closed	-$691K	–	1228
2017 Q3	$691K	Buy	+34,828	New	+$684K	0.11%	313

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's NVCR Position: Q4 2022 in Review

Dynamic Technology Lab sold out of NovoCure (NVCR) in Q4 2022, closing a stake of 3,910 shares — an estimated $297K sold.

Dynamic Technology Lab first reported a position in NVCR in Q3 2017 and held it in 6 quarters. The position peaked at $1.67M in Q2 2020. 304 funds tracked by Wall St. Rank hold NVCR as of Q4 2022.

Dynamic Technology Lab reported no remaining NovoCure position as of Q4 2022 after selling out during the quarter.
Dynamic Technology Lab sold 3,910 NovoCure shares in Q4 2022, an estimated $297K.
Dynamic Technology Lab first reported a position in NovoCure in Q3 2017 and held it in 6 quarters.
Dynamic Technology Lab's NovoCure position peaked at $1.67M in Q2 2020.
304 funds tracked by Wall St. Rank held NovoCure as of Q4 2022.

Based on Dynamic Technology Lab's 13F filing for Q4 2022, filed 14 Feb 2023.